MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Improving EVAR Through Simulation Training
Integrating scrub nurses into simulated training programs results in improved patient safety and job satisfaction.
By Rebecca Skov, MD; Jonathan Lawaetz, MD, PhD; Lise Westerlin, RN; Timothy Resch, MD, PhD; and Jonas Eiberg, MD, PhD
The Evolving PAD Patient Population: How Is It Changing?
Recognition of generational trends and their impact on decision-making and patient care.
With moderator Peter A. Schneider, MD, and panelists Joshua Beckman, MD; Sabine Steiner, MD; and Kevin Rogers, MD
WAIS at 55: Wellness and Progress
Ahead of the Western Angiographic & Interventional Society’s 55th anniversary, WAIS leadership discuss the society’s origins and goals for the future, the value of a regional-based meeting, the importance of focusing on physician wellness, and what to expect at the annual meeting in September.
With Sabeen Dhand, MD; John D. Louie, MD; and Susan Jackson, MBA
Venous Issues
By Barry T. Katzen, MD
Improving Infrapopliteal Balloon Angioplasty Results
A new generation of long balloons for treating diabetics and nondiabetics.
By Lanfroi Graziani, MD
Sponsored by Cook Medical
Seeing the Signs
The top precursors/predictors for earlier endovascular treatment versus medical management of type B aortic dissection.
By Worawong Slisatkorn, MD
Varicose and Telangiectatic Leg Veins
Principles for successful sclerotherapy treatment of varicose and telangiectatic leg veins.
By Mitchel P. Goldman, MD
Sponsored by Medtronic
The Aortic Center Tool Kit: Pathway for Institutional Growth
By David Loran, MD; Apostolos K. Tassiopoulos, MD; Chantay Coulter, RN; and Olympia Christoforatos, RN, MS
Sponsored by TriVascular, Inc.
Preserving the Aortic Neck
Why the O-ring sealing technology of the Ovation Prime® System does not contribute to aortic neck dilatation.
By Sean P. Lyden, MD
Review of Chronic Venous Insufficiency
From vein stripping to endovenous ablation, a look at the various techniques available for treatment.
By Olusegun O. Osinbowale, MD, and Yung-Wei Chi, DO
Determining Cost-Effectiveness in CLI Therapy
Weighing clinical benefits along with cost when selecting therapies is more important than ever.
By Firas F. Mussa, MD, MS, with commentary by Mary L. Yost, MBA
PIVOTAL Trial Update
With enrollment more than half complete, the PIVOTAL trial aims to answer the question of the best treatment model for patients with small aneurysms.
By Daniel G. Clair, MD, and Kenneth Ouriel, MD
Cook Medical's Zenith Alpha Approved and Launched in Canada
December 10, 2015—Cook Medical announced the commercial launch of the Zenith Alpha abdominal endovascular graft in Canada, where it recently received Canadian approval.
A Global Perspective on Dialysis Access
Ingemar A. Davidson, MD, PhD, discusses the differences in end-stage renal disease treatment around the globe and how practitioners can join forces to provide the best care possible.
Long Peripheral CTOs: Femoropopliteal to Mid and Distal Tibial Arteries
Proper patient assessment and current access and revascularization techniques to treat challenging CLI anatomy.
By J.A. Mustapha, MD, and Fadi Saab, MD
Adjunctive Imaging Modalities in Endovascular Therapy for CLI
Utilizing ultrasound-guided access, IVUS, and OCT to deliver current state-of-the-science endovascular treatments for patients with critical limb ischemia.
By Jihad A. Mustapha, MD, FACC, FSCAI; Fadi Saab; Larry J. Diaz-Sandoval, MD; and Barbara Karenko, DO
Aortic Neck Dilatation: Causes and Effects
A look at the mechanisms of aortic neck dilatation and how they can be overcome with new technology.
VEIN: The Venous Ulcer Platform Study
Developing an adaptive platform trial for venous leg ulceration.
By Sarah Onida, BSc, PhD, FRCS; Francine Heatley, BSc, PhD; and Alun H. Davies, MA, DM, DSc, FRCS, FHEA, FEBVS, FACPh, FFST(Ed)
Sirtex Completes Enrollment in FOXFIRE and FOXFIRE Global Studies
January 29, 2015—Sirtex Medical Limited announced the completion of patient enrollment in the FOXFIRE and FOXFIRE Global studies of the addition of liver-directed radiation therapy with the company’s SIR-Spheres Y-90 resin microspheres to a current standard-of-care chemotherapy regimen in the first-line treatment of more than 560 patients recently diagnosed with inoperable metastatic colorectal cancer (mCRC).
